Quantitative-Proteomic Comparison of Alpha and Beta Cells to Uncover Novel Targets for Lineage Reprogramming
Type-1 diabetes (T1D) is an autoimmune disease in which insulin-secreting pancreatic beta cells are destroyed by the immune system. An emerging strategy to regenerate beta-cell mass is through transdifferentiation of pancreatic alpha cells to beta cells. We previously reported two small molecules, B...
Main Authors: | Choudhary, Amit, Hu He, Kaihui, Mertins, Philipp, Udeshi, Namrata D., Dancik, Vlado, Fomina-Yadlin, Dina, Kubicek, Stefan, Clemons, Paul A., Schreiber, Stuart L., Wagner, Bridget K., Carr, Steven A |
---|---|
Other Authors: | Koch Institute for Integrative Cancer Research at MIT |
Format: | Article |
Language: | en_US |
Published: |
Public Library of Science
2014
|
Online Access: | http://hdl.handle.net/1721.1/88043 https://orcid.org/0000-0002-7203-4299 |
Similar Items
-
Uncovering Neurodegenerative Protein Modifications via Proteomic Profiling
by: Gallart-Palau, Xavier, et al.
Published: (2015) -
Proteomic Mapping of Mitochondria in Living Cells via Spatially Restricted Enzymatic Tagging
by: Martell, Jeffrey Daniel, et al.
Published: (2015) -
Proteomic mapping in live Drosophila tissues using an engineered ascorbate peroxidase
by: Chen, Chiao-Lin, et al.
Published: (2016) -
Chromatin-targeting small molecules cause class-specific transcriptional changes in pancreatic endocrine cells
by: Kubicek, Stefan, et al.
Published: (2012) -
Spatially resolved proteomic mapping in living cells with the engineered peroxidase APEX2
by: Hung, Victoria, et al.
Published: (2016)